Clinical trial

Neurodevelopmental Effects of Donor Human Milk vs. Preterm Formula in Extremely Low Birth Weight (ELBW) Infants

Name
NICHD-NRN-0047
Description
The Milk Trial seeks to determine the effect on neurodevelopmental outcomes at age 22-26 months of donor human milk as compared to preterm infant formula as the in-hospital diet for infants whose mothers choose not to provide breast milk or are able to provide only a minimal amount. Infants will be randomized to receive donor breast milk or formula during their hospital stay. Infant's will be followed until they reach 22-26 months of age.
Trial arms
Trial start
2012-08-01
Estimated PCD
2021-11-30
Trial end
2021-11-30
Status
Completed
Phase
Early phase I
Treatment
Donor Milk
Donor milk provided by the Human Milk Banking Association of North America
Arms:
Donor Milk
Preterm Formula
Preterm Formula determined by center practice.
Arms:
Preterm Formula
Size
483
Primary endpoint
Bayley Scales of Infant Development (BSID) Cognitive Composite Score
At 22-26 months corrected age
Eligibility criteria
Inclusion Criteria: * Gestational age less than 29 weeks. * Admitted to the NICU at less than or equal to 72 hours of life * Survived at least 12 hours Exclusion Criteria: * Chromosomal anomalies * Cyanotic congenital heart disease * Diagnosed intrauterine infection * Other congenital disorders known to impair neurodevelopment * NEC or IP prior to seeking consent * Decision documented to limit intensive care therapies * Congenital disorders that may affect feeding Feeding Group Eligibility: * Sole Diet Group: Infants will be eligible for the sole diet feeding protocol if the mother declines to provide breast milk for the baby. * Supplemental Diet (minimal maternal milk) Group: Infants whose mothers initially choose to provide breast milk and begin pumping will be re-screened for eligibility at least weekly until the infant is 21 days old. If the mother stops expressing milk at any point prior to the infant's 21st day of life, her infant will be eligible for randomization. In addition, those whose mothers are providing less than 20% of the infant's dietary needs (averaged over past 5 days) when the infant reaches 21 days of age will be eligible for randomization at this point. No infant will be randomized after reaching 21 days.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE3'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'PREVENTION', 'maskingInfo': {'masking': 'QUADRUPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 483, 'type': 'ACTUAL'}}
Updated at
2023-02-06

1 organization

1 product

4 indications

Product
Donor Milk
Indication
Infant
Indication
Newborn